CDK4 activity in mouse embryos expressing a single D-type cyclin

International Journal of Developmental Biology

Volumn 52, Issue 2-3, 2008, Pages 299-305

  Ciemerych, Maria A ^a   Yu, Qunyan ^b,c   Szczepanska, Katarzyna ^a   Sicinski, Piotr ^b  

^a UNIVERSITY OF WARSAW   (Poland)

^b HARVARD MEDICAL SCHOOL   (United States)

^c NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

CDK4; Cyclin D; Embryogenesis; Mouse; p27kip1; Retinoblastoma protein

Indexed keywords

CYCLIN D1; CYCLIN D2; CYCLIN D3; CYCLIN DEPENDENT KINASE 4;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EMBRYO DEVELOPMENT; ENZYME ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ANIMALS; BLOTTING, WESTERN; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLINS; EMBRYONIC DEVELOPMENT; FEMALE; IMMUNOPRECIPITATION; IN SITU HYBRIDIZATION; MALE; MICE; MICE, KNOCKOUT; PHOSPHORYLATION; PREGNANCY; RETINOBLASTOMA PROTEIN;

EID: 42349116970     PISSN: 02146282     EISSN: None     Source Type: Journal    
DOI: 10.1387/ijdb.072336mc     Document Type: Article

References (56)

1. AGUZZI, A., KIESS, M., RUED, D. and HAMEL, P.A. (1996). Cyclins D1, D2 and D3 are expressed in distinct tissues during mouse embryogenesis. Transgenics 2: 29-39.
2. BAGUI, T.K., JACKSON, R.J., AGRAWAL, D. and PLEDGER, W.J. (2000). Analysis of cyclin D3-cdk4 complexes in fibroblasts expressing and lacking p27(kip1) and p21(cip1). Mol Cell Biol 20: 8748-57.
3. BIENVENU, F., GASCAN, H. and COQUERET, O. (2001). Cyclin D1 represses stat3 activation through a cdk4-independent mechanism. J Biol Chem 276: 16840-7.
4. BLAIN, S.W., MONTALVO, E. and MASSAGUE, J. (1997). Differential interaction of the cyclin-dependent kinase (cdk) inhibitor p27kip1 with cyclin A-cdk2 and cyclin D2-cdk4. J Biol Chem 272: 25863-72.
5. CARTHON, B.C., NEUMANN, C.A., DAS, M., PAWLYK, B., LI, T., GENG, Y. and SICINSKI, P. (2005). Genetic replacement of cyclin D1 function in mouse development by cyclin D2. Mol Cell Biol 25: 1081-8.
6. CHENG, M., OLIVIER, P., DIEHL, J.A., FERO, M., ROUSSEL, M.F., ROBERTS, J.M. and SHERR, C.J. (1999). The p21cip1 and p27kip1 cdk 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. Embo J 18: 1571-1583.
7. CHENG, M., SEXL, V., SHERR, C.J. and ROUSSEL, M.F. (1998). Assembly of cyclin D-dependent kinase and titration of p27kip1 regulated by mitogen-activated protein kinase kinase (mek1). Proc Natl Acad Sci USA 95: 1091-6.
8. CIEMERYCH, M.A., KENNEY, A.M., SICINSKA, E., KALASZCZYNSKA, I., BRONSON, R.T., ROWITCH, D.H., GARDNER, H. and SICINSKI, P. (2002). Development of mice expressing a single D-type cyclin. Genes Dev 16: 3277-89.
9. CIEMERYCH, M.A. and SICINSKI, P. (2005). Cell cycle in mouse development. Oncogene 24: 2877-98.
10. COQUERET, O. (2002). Linking cyclins to transcriptional control. Gene 299: 35-55.
11. DEL TURCO, D., GEBHARDT, C., BURBACH, G.J., PLEASURE, S.J., LOWENSTEIN, D.H. and DELLER, T. (2004). Laminar organization of the mouse dentate gyrus: Insights from beta2/neuro D mutant mice. J Comp Neurol 477: 81-95.
12. DIMOVA, D.K. and DYSON, N.J. (2005). The E2F transcriptional network: Old acquaintances with new faces. Oncogene 24: 2810-26.
13. FANTL, V., STAMP, G., ANDREWS, A., ROSEWELL, I. and DICKSON, C. (1995). Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. Genes Dev 9: 2364-72.
14. FUKUDA, S. and TAGA, T. (2005). Cell fate determination regulated by a transcriptional signal network in the developing mouse brain. Anat Sci Int 80: 12-8.
15. GENG, Y., YU, Q., SICINSKA, E., DAS, M., BRONSON, R.T. and SICINSKI, P. (2001). Deletion of the p27kip1 gene restores normal development in cyclin D1-deficient mice. Proc Natl Acad Sci USA 98: 194-9.
16. HABENER, J.F., KEMP, D.M. and THOMAS, M.K. (2005). Minireview: Transcriptional regulation in pancreatic development. Endocrinology 146: 1025-34.
17. HALL, M., BATES, S. and PETERS, G. (1995). Evidence for different modes of action of cyclin-dependent kinase inhibitors: p15 and p16 bind to kinases, p21 and p27 bind to cyclins. Oncogene 11: 1581-8.
18. HARPER, J.W., ADAMI, G.R., WEI, N., KEYOMARSI, K. and ELLEDGE, S.J. (1993). The p21 cdk-interacting protein cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-16.
19. HIRAI, H. and SHERR, C.J. (1996). Interaction of d-type cyclins with a novel myb-like transcription factor, DMP1. Mol Cell Biol 16: 6457-67.
20. HUARD, J.M., FORSTER, C.C., CARTER, M.L., SICINSKI, P. and ROSS, M.E. (1999). Cerebellar histogenesis is disturbed in mice lacking cyclin D2. Development 126: 1927-35.
21. INOUE, K. and SHERR, C.J. (1998). Gene expression and cell cycle arrest mediated by transcription factor DMP1 is antagonized by d-type cyclins through a cyclin-dependent-kinase-independent mechanism. Mol Cell Biol 18: 1590-600.
22. KALDIS, P. (1999). The cdk-activating kinase (CAK): From yeast to mammals. Cell Mol Life Sci 55: 284-96.
23. KHATIB, Z.A., MATSUSHIME, H., VALENTINE, M., SHAPIRO, D.N., SHERR, C.J. and LOOK, A.T. (1993). Coamplification of the cdk4 gene with mdm2 and gli in human sarcomas. Cancer Res 53: 5535-41.
24. KNUDSEN, K.E., CAVENEE, W.K. and ARDEN, K.C. (1999). D-type cyclins complex with the androgen receptor and inhibit its transcriptional transactivation ability. Cancer Res 59: 2297-301.
25. KOZAR, K., CIEMERYCH, M.A., REBEL, V.I., SHIGEMATSU, H., ZAGOZDZON, A., SICINSKA, E., GENG, Y., YU, Q., BHATTACHARYA, S., BRONSON, R.T. et al. (2004). Mouse development and cell proliferation in the absence of D-cyclins. Cell 118: 477-91.
26. KOZAR, K. and SICINSKI, P. (2005). Cell cycle progression without cyclin D-cdk4 and cyclin D-cdk6 complexes. Cell Cycle 4: 388-91.
27. KUSHNER, J.A., CIEMERYCH, M.A., SICINSKA, E., WARTSCHOW, L.M., TETA, M., LONG, S.Y., SICINSKI, P. and WHITE, M.F. (2005). Cyclins D2 and D1 are essential for postnatal pancreatic beta-cell growth. Mol Cell Biol 25: 3752-62.
28. LABAER, J., GARRETT, M.D., STEVENSON, L.F., SLINGERLAND, J.M., SANDHU, C., CHOU, H.S., FATTAEY, A. and HARLOW, E. (1997). New functional activities for the p21 family of cdk inhibitors. Genes Dev 11: 847-62.
29. LAMB, J., RAMASWAMY, S., FORD, H.L., CONTRERAS, B., MARTINEZ, R.V., KITTRELL, F.S., ZAHNOW, C.A., PATTERSON, N., GOLUB, T.R. and EWEN, M.E. (2003). A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer. Cell 114: 323-34.
30. LANDIS, M.W., PAWLYK, B.S., LI, T., SICINSKI, P. and HINDS, P.W. (2006). Cyclin D1-dependent kinase activity in murine development and mammary tumorigenesis. Cancer Cell 9: 13-22.
31. LEE, M.H., REYNISDOTTIR, I. and MASSAGUE, J. (1995). Cloning of p57kip2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev 9: 639-49.
32. LIU, M., PLEASURE, S.J., COLLINS, A.E., NOEBELS, J.L., NAYA, F.J., TSAI, M.J. and LOWENSTEIN, D.H. (2000). Loss of beta2/neuro D leads to malformation of the dentate gyrus and epilepsy. Proc Natl Acad Sci USA 97: 865-70.
33. MALUMBRES, M., SOTILLO, R., SANTAMARIA, D., GALAN, J., CEREZO, A., ORTEGA, S., DUBUS, P. and BARBACID, M. (2004). Mammalian cells cycle without the d-type cyclin-dependent kinases cdk4 and cdk6. Cell 118: 493-504.
34. MATSUSHIME, H., QUELLE, D.E., SHURTLEFF, S.A., SHIBUYA, M., SHERR, C.J. and KATO, J.Y. (1994). D-type cyclin-dependent kinase activity in mammalian cells. Mol Cell Biol 14: 2066-76.
35. MATSUSHIME, H., ROUSSEL, M.F., ASHMUN, R.A. and SHERR, C.J. (1991). Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell 65: 701-13.
36. NAKAYAMA, K., NAGAHAMA, H., MINAMISHIMA, Y.A., MIYAKE, S., ISHIDA, N., HATAKEYAMA, S., KITAGAWA, M., IEMURA, S., NATSUME, T. and NAKAYAMA, K.I. (2004). Skp2-mediated degradation of p27 regulates progression into mitosis. Dev Cell 6: 661-72.
37. NEUMAN, E., LADHA, M.H., LIN, N., UPTON, T.M., MILLER, S.J., DI RENZO, J., PESTELL, R.G., HINDS, P.W., DOWDY, S.F., BROWN, M. et al. (1997). Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4. Mol Cell Biol 17: 5338-47.
38. NIGG, E.A. (2001). Cell cycle regulation by protein kinases and phosphatases. Ernst Schering Res Found Workshop19-46.
39. PAGANO, M. (2004). Control of DNA synthesis and mitosis by the Skp2-p27-cdk1/2 axis. Mol Cell 14: 414-6.
40. POGORILER, J., MILLEN, K., UTSET, M. and DU, W. (2006). Loss of cyclin D1 impairs cerebellar development and suppresses medulloblastoma formation. Development 133: 3929-37.
41. POLYAK, K., LEE, M.H., ERDJUMENT-BROMAGE, H., KOFF, A., ROBERTS, J.M., TEMPST, P. and MASSAGUE, J. (1994). Cloning of p27kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78: 59-66.
42. RATINEAU, C., PETRY, M.W., MUTOH, H. and LEITER, A.B. (2002). Cyclin D1 represses the basic helix-loop-helix transcription factor, beta2/neuroD. J Biol Chem 277: 8847-53.
43. RAVNIK, S.E., RHEE, K. and WOLGEMUTH, D.J. (1995). Distinct patterns of expression of the D-type cyclins during testicular development in the mouse. Dev Genet 16: 171-8.
44. ROBKER, R.L. and RICHARDS, J.S. (1998). Hormone-induced proliferation and differentiation of granulosa cells: A coordinated balance of the cell cycle regulators cyclin D2 and p27kip1. Mol Endocrinol 12: 924-40.
45. SICINSKA, E., AIFANTIS, I., LE CAM, L., SWAT, W., BOROWSKI, C., YU, Q., FERRANDO, A.A., LEVIN, S.D., GENG, Y., VON BOEHMER, H. et al. (2003). Requirement for cyclin D3 in lymphocyte development and t cell leukemias. Cancer Cell 4: 451-61.
46. SICINSKI, P., DONAHER, J.L., GENG, Y., PARKER, S.B., GARDNER, H., PARK, M.Y., ROBKER, R.L., RICHARDS, J.S., MCGINNIS, LK., BIGGERS, J.D. et al. (1996). Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis. Nature 384: p470-4.
47. SICINSKI, P., DONAHER, J.L., PARKER, S.B., LI, T., FAZELI, A., GARDNER, H., HASLAM, S.Z., BRONSON, R.T., ELLEDGE, S.J. and WEINBERG, R.A. (1995). Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 82: 621-30.
48. SKAPEK, S.X., RHEE, J., SPICER, D.B. and LASSAR, A.B. (1995). Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase. Science 267: 1022-4.
49. SOOS, T.J., KIYOKAWA, H., YAN, J.S., RUBIN, M.S., GIORDANO, A., DEBLASIO, A., BOTTEGA, S., WONG, B., MENDELSOHN, J. and KOFF, A. (1996). Formation of p27-cdk complexes during the human mitotic cell cycle. Cell Growth Differ 7: 135-46.
50. SUGIMOTO, M., MARTIN, N., WILKS, D.P., TAMAI, K., HUOT, T.J., PANTOJA, C., OKUMURA, K., SERRANO, M. and HARA, E. (2002). Activation of cyclin D1-kinase in murine fibroblasts lacking both p21(cip1) and p27(kip1). Oncogene 21: 8067-74.
51. TONG, W. and POLLARD, J.W. (2001). Genetic evidence for the interactions of cyclin D1 and p27(kip1) in mice. Mol Cell Biol 21: 1319-28.
52. TOYOSHIMA, H. and HUNTER, T. (1994). p27, a novel inhibitor of G1 cyclin-cdk protein kinase activity, is related to p21. Cell 78: 67-74.
53. VIDAL, A. and KOFF, A. (2000). Cell-cycle inhibitors: Three families united by a common cause. Gene 247: 1-15.
54. YU, Q., CIEMERYCH, M.A. and SICINSKI, P. (2005). Ras and myc can drive oncogenic cell proliferation through individual D-cyclins. Oncogene 24: 7114-9.
55. ZARKOWSKA, T. and MITTNACHT, S. (1997). Differential phosphorylation of the retinoblastoma protein by G1/S cyclin-dependent kinases. J Biol Chem 272: 12738-46.
56. ZWIJSEN, R.M., WIENTJENS, E., KLOMPMAKER, R., VAN DER SMAN, J., BERNARDS, R. and MICHALIDES, R.J. (1997). Cdk-independent activation of estrogen receptor by cyclin D1. Cell 88: 405-15.